HealthEquity price target raised to $130 from $110 at BTIG

BTIG raised the firm’s price target on HealthEquity (HQY) to $130 from $110 and keeps a Buy rating on the shares. The firm is citing improving policy fundamentals, better visibility into demand trends, and a healthy economy and labor market in updating its model, the analyst tells investors in a research note. BTIG adds that as health-tech and services moves closer to the consumer with digital products, HealthEquity’s incoming CEO Scott Cutler will help facilitate growth.